Bỉ - Tiếng Anh - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - timolol maleate 6,83 mg/ml - eq. timolol 5 mg/ml; dorzolamide hydrochloride 22,26 mg/ml - eq. dorzolamide 20 mg/ml - eye drops, solution - 20 mg/ml - 5 mg/ml - timolol maleate 6.83 mg/ml; dorzolamide hydrochloride 22.26 mg/ml - timolol, combinations

Bỉ - Tiếng Anh - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - dorzolamide hydrochloride 22,26 mg/ml - eq. dorzolamide 20 mg/ml; timolol maleate 6,83 mg/ml - eq. timolol 5 mg/ml - eye drops, solution - 20 mg/ml - 5 mg/ml - dorzolamide hydrochloride 22.26 mg/ml; timolol maleate 6.83 mg/ml - timolol, combinations

Canada - Tiếng Anh - Health Canada

angita pharma inc. - timolol (timolol maleate); dorzolamide (dorzolamide hydrochloride) - solution - 5mg; 20mg - timolol (timolol maleate) 5mg; dorzolamide (dorzolamide hydrochloride) 20mg

Kenya - Tiếng Anh - Pharmacy and Poisons Board

micro labs limited #31, race course road, bangalore 560 001 - dorzolamide hydrochloride and timolol maleate - ophthalmic solution - 2%w/v dozolamide and 0.5%w/v timolol - timolol combinations

Ai-len - Tiếng Anh - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - dorzolamide ; timolol - eye drops solution - 20+5 mg/ml - timolol, combinations

Israel - Tiếng Anh - Ministry of Health

rafa laboratories ltd - dorzolamide as hydrochloride - ophthalmic solution - dorzolamide as hydrochloride 20 mg/ml - dorzolamide - dorzolamide - for the treatment of eleveated intraocular pressure in patients with ocular hypertension, open-angle glaucoma and in some patients secondary glaucoma.

Kenya - Tiếng Anh - Pharmacy and Poisons Board

indoco remedies limited "l-32, 33 & 34 verna industrial area, verna, goa, - dorzolamide hydrochloride timolol maleate - eye drops - "dorzolamide hydrochloride.20 mg timolol maleate… - ophthalmological antiglaucoma preparations and

Ai-len - Tiếng Anh - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd t/a gerard laboratories - dorzolamide hydrochloride timolol maleate - eye drops solution - 20+5 mg/ml

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

bausch & lomb incorporated - dorzolamide hydrochloride (unii: qzo5366ew7) (dorzolamide - unii:9jdx055tw1) - dorzolamide 20 mg in 1 ml - dorzolamide hydrochloride ophthalmic solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. dorzolamide hydrochloride ophthalmic solution is contraindicated in patients who are hypersensitive to any component of this product [see warnings and precautions (5.1)] . risk summary there are no adequate and well-controlled studies in pregnant women with dorzolamide hydrochloride ophthalmic solution. dorzolamide caused fetal vertebral malformations when administered orally to rabbits at 2.5 mg/kg/day (37 times the clinical exposure). dorzolamide administered during the period of organogenesis was not teratogenic in rabbits dosed up to 1 mg/kg/day (15 times the clinical exposure). dorzolamide hydrochloride administered orally to rats during late gestation and lactation caused growth delays in offspring at 7.5 mg/kg/day (52 times the clinical exposure). growth was not delayed at 1 mg/kg/day (8.0 times the clinical exposure). the background r

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

sandoz inc - dorzolamide hydrochloride (unii: qzo5366ew7) (dorzolamide - unii:9jdx055tw1) - dorzolamide 20 mg in 1 ml - dorzolamide hydrochloride ophthalmic solution, 2% is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. dorzolamide hydrochloride ophthalmic solution is contraindicated in patients who are hypersensitive to any component of this product [see warnings and precautions (5.1)]. there are no adequate and well-controlled studies in pregnant women with dorzolamide hydrochloride ophthalmic solution. dorzolamide caused fetal vertebral malformations when administered orally to rabbits at 2.5 mg/kg/day (37 times the clinical exposure). dorzolamide administered during the period of organogenesis was not teratogenic in rabbits dosed up to 1 mg/kg/day (15 times the clinical exposure). dorzolamide hydrochloride administered orally to rats during late gestation and lactation caused growth delays in offspring at 7.5 mg/kg/day (52 times the clinical exposure). growth was not delayed at 1 mg/kg/day (8.0 times the clinical exposure). the background risk of maj